休克机械通气成人早期肠内与肠外营养比较:NUTRIREA-2随机对照多中心开放平行组研究
NUTRIREA-2研究在44个法国ICU纳入2410例接受有创机械通气和血管活性药物支持的休克成人,随机1:1分配至肠内营养或肠外营养,均于插管后24小时内启动,目标等热卡20-25 kcal/kg/天。28天死亡率肠内组37%(443/1202)vs肠外组35%(422/1208),绝对差2.0%(95%CI -1.9至5.8;p=0.33),无显著差异。ICU获得性感染累积发生率肠内组14%(173例)vs肠外组16%(194例),HR 0.89(95%CI 0.72-1.09;p=0.25),无显著差异。肠内组呕吐、腹泻、肠缺血和急性结肠假性梗阻的累积发生率均高于肠外组。
要点
- 休克机械通气成人早期等热卡肠内营养组28天死亡率37%(443/1202)vs肠外营养组35%(422/1208),绝对差2.0%(95%CI -1.9至5.8;p=0.33),无显著差异。
- ICU获得性感染累积发生率肠内组14%(173例)vs肠外组16%(194例),HR 0.89(95%CI 0.72-1.09;p=0.25),无显著差异。
- 肠内组呕吐34%(406例)vs肠外组20%(246例),HR 1.89(95%CI 1.62-2.20;p<0.0001)。
- 肠内组肠缺血2%(19例)vs肠外组<1%(5例),HR 3.84(95%CI 1.43-10.3;p=0.007);急性结肠假性梗阻肠内组1%(11例)vs肠外组<1%(3例),HR 3.7(95%CI 1.03-13.2;p=0.04)。
- 作者结论:休克危重成人早期等热卡肠内营养未降低死亡率或继发感染风险,但消化道并发症风险高于早期等热卡肠外营养。
适用人群与场景
- 18岁及以上成人,接受有创机械通气并因休克接受血管活性药物支持,在插管后24小时内启动营养支持。
- 研究在44个法国ICU进行。
诊断标准与关键阈值
- 肠外营养组可在休克缓解(连续24小时无血管活性药物支持且动脉乳酸<2 mmol/L)后至少72小时转换为肠内营养。
处置流程与药物剂量
- 肠内营养组:插管后24小时内启动肠内营养,目标等热卡20-25 kcal/kg/天。
- 肠外营养组:插管后24小时内启动肠外营养,目标等热卡20-25 kcal/kg/天;休克缓解(连续24小时无血管活性药物支持且动脉乳酸<2 mmol/L)后至少72小时可转换为肠内营养。
红旗征与不能漏的情况
- 肠内营养组呕吐累积发生率34%(406例)vs肠外营养组20%(246例),HR 1.89(95%CI 1.62-2.20;p<0.0001)。
- 肠内营养组腹泻累积发生率36%(432例)vs肠外营养组33%(393例),HR 1.20(95%CI 1.05-1.37;p=0.009)。
- 肠内营养组肠缺血累积发生率2%(19例)vs肠外营养组<1%(5例),HR 3.84(95%CI 1.43-10.3;p=0.007)。
- 肠内营养组急性结肠假性梗阻累积发生率1%(11例)vs肠外营养组<1%(3例),HR 3.7(95%CI 1.03-13.2;p=0.04)。
研究设计与关键结果
- 研究类型:随机、对照、多中心、开放标签、平行组研究(NUTRIREA-2),在44个法国ICU进行。
- 样本量:共纳入2410例,肠内营养组1202例,肠外营养组1208例。
- 主要终点:28天死亡率肠内组37%(443/1202)vs肠外组35%(422/1208),绝对差2.0%(95%CI -1.9至5.8;p=0.33),无显著差异。
- 关键次要终点:ICU获得性感染累积发生率肠内组14%(173例)vs肠外组16%(194例),HR 0.89(95%CI 0.72-1.09;p=0.25),无显著差异。
- 不良事件:肠内组呕吐34%(406例)vs肠外组20%(246例),HR 1.89(95%CI 1.62-2.20;p<0.0001);腹泻肠内组36%(432例)vs肠外组33%(393例),HR 1.20(95%CI 1.05-1.37;p=0.009);肠缺血肠内组2%(19例)vs肠外组<1%(5例),HR 3.84(95%CI 1.43-10.3;p=0.007);急性结肠假性梗阻肠内组1%(11例)vs肠外组<1%(3例),HR 3.7(95%CI 1.03-13.2;p=0.04)。
- 研究因第二次中期分析后独立数据安全监察委员会认为完成入组不太可能显著改变试验结果而建议停止招募。
证据类型、等级与局限
- 证据类型:随机对照试验(RCT)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于接受有创机械通气和血管活性药物支持的休克成人,早期等热卡肠内营养与早期等热卡肠外营养相比,28天死亡率和ICU获得性感染风险无显著差异。
- 作者结论:早期等热卡肠内营养未降低死亡率或继发感染风险,但消化道并发症风险高于早期等热卡肠外营养。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Whether the route of early feeding affects outcomes of patients with severe critical illnesses is controversial. We hypothesised that outcomes were better with early first-line enteral nutrition than with early first-line parenteral nutrition.
METHODS: In this randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2 trial) done at 44 French intensive-care units (ICUs), adults (18 years or older) receiving invasive mechanical ventilation and vasopressor support for shock were randomly assigned (1:1) to either parenteral nutrition or enteral nutrition, both targeting normocaloric goals (20-25 kcal/kg per day), within 24 h after intubation. Randomisation was stratified by centre using permutation blocks of variable sizes. Given that route of nutrition cannot be masked, blinding of the physicians and nurses was not feasible. Patients receiving parenteral nutrition could be switched to enteral nutrition after at least 72 h in the event of shock resolution (no vasopressor support for 24 consecutive hours and arterial lactate <2 mmol/L). The primary endpoint was mortality on day 28 after randomisation in the intention-to-treat-population. This study is registered with ClinicalTrials.gov, number NCT01802099.
FINDINGS: After the second interim analysis, the independent Data Safety and Monitoring Board deemed that completing patient enrolment was unlikely to significantly change the results of the trial and recommended stopping patient recruitment. Between March 22, 2013, and June 30, 2015, 2410 patients were enrolled and randomly assigned; 1202 to the enteral group and 1208 to the parenteral group. By day 28, 443 (37%) of 1202 patients in the enteral group and 422 (35%) of 1208 patients in the parenteral group had died (absolute difference estimate 2·0%; [95% CI -1·9 to 5·8]; p=0·33). Cumulative incidence of patients with ICU-acquired infections did not differ between the enteral group (173 [14%]) and the parenteral group (194 [16%]; hazard ratio [HR] 0·89 [95% CI 0·72-1·09]; p=0·25). Compared with the parenteral group, the enteral group had higher cumulative incidences of patients with vomiting (406 [34%] vs 246 [20%]; HR 1·89 [1·62-2·20]; p<0·0001), diarrhoea (432 [36%] vs 393 [33%]; 1·20 [1·05-1·37]; p=0·009), bowel ischaemia (19 [2%] vs five [<1%]; 3·84 [1·43-10·3]; p=0·007), and acute colonic pseudo-obstruction (11 [1%] vs three [<1%]; 3·7 [1·03-13·2; p=0·04).
INTERPRETATION: In critically ill adults with shock, early isocaloric enteral nutrition did not reduce mortality or the risk of secondary infections but was associated with a greater risk of digestive complications compared with early isocaloric parenteral nutrition.
FUNDING: La Roche-sur-Yon Departmental Hospital and French Ministry of Health.
参考来源
- Reignier J, Boisramé-Helms J, Brisard L, et al. Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2). Lancet. 2017. PMID: 29128300. doi:10.1016/S0140-6736(17)32146-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。